This week, we’re sharing the most recent top stories in psychiatry news.
Read more on these stories below:
What You Should Know to Care for LGBTQ Patients American Psychiatric Association Publishing, May 24, 2021
The recognition that sexual orientations and gender identities are expanding has presented new treatment challenges to psychiatrists.
FDA Approves Controversial Alzheimer’s Drug Aducanumab (Aduhelm) Medscape Medical News, June 7, 2021
Disregarding the recommendation from its advisory panel, the FDA has approved the controversial anti-amyloid aducanumab for Alzheimer’s disease.
‘Remarkable’ Response to Diabetes Drug in Resistant Bipolar Depression Medscape Medical News, June 7, 2021
Patients with treatment-resistant bipolar depression with insulin resistance showed marked improvement in depressive symptoms after their insulin-resistance was mitigated by treatment with metformin.
Childhood insomnia that persists into adulthood impacts mental health of young adults Healio, June 10, 2021
Childhood-onset insomnia symptoms that continued into adulthood served as “strong determinants” of internalizing disorders in young adults, according to findings from a 15-year longitudinal study presented at the virtual SLEEP 2021 meeting.
Data collected via smartphones, wearables may help personalize depression treatment Healio, June 10, 2021
A digital data-driven approach was able to predict depression and allow for personalized treatment, according to study results published in Translational Psychiatry.